CI U.S. Stock Selection Corporate Class

Series E USD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies in the United States.

Fund details

description of elementelement value
Inception date July 2011
CAD Total net assets ($CAD)
As at 2026-10-30
$262.5 million
NAVPS
As at 2026-11-10
$24.4036
MER (%)
As at 2026-03-31
2.33
Management fee (%) 1.95
Units outstanding
As at
-
Asset class U.S. Equity
Currency USD
Minimum investment $100,000 initial/$5,000 additional
Distribution frequency Quarterly
Last distribution $0.2026

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

E 17122
A ISC 512
DSC SO* 513
LL SO 1513
F 515
I 5500
O 19122
P 90318
*No new purchases directly into switch only funds.

Performance2 As at 2026-10-31

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
12.77% 1.58% 8.09% 26.82% 17.46% 17.94% 9.41% 10.76% 11.15%
*Since inception date

Distribution history3

Payable date Total
2026-09-25 0.2026
2026-06-26 0.2026
2026-03-27 0.4057
2025-03-28 0.4986
2022-12-16 0.5706
Payable date Total
2022-09-23 0.5809
2022-06-24 0.5813
2022-03-25 1.0293
2021-03-26 0.3605
2020-12-18 0.2136

Management team

First we'll display the Team Company and then the Team members
Jeremy Rosa
Aubrey Hearn

CI U.S. Stock Selection Corporate Class

Series E USD
 
Portfolio allocations4 As at 2026-10-31
Asset allocation (%)
  • US Equity 92.55
  • International Equity 6.73
  • Canadian Equity 0.44
  • Cash and Equivalents 0.32
  • Other -0.04
Sector allocation (%)
  • Technology 53.76
  • Healthcare 32.25
  • Consumer Services 8.44
  • Financial Services 5.27
  • Cash and Cash Equivalent 0.32
  • Other -0.04
Geographic allocation(%)
  • United States 92.51
  • Taiwan 2.01
  • Netherlands 1.97
  • United Kingdom 1.73
  • Ireland 1.02
  • Canada 0.80
  • Other -0.04
Top holdings6
Sector (%)
1. NVIDIA Corp Computer Electronics 10.39%
2. Microsoft Corp Information Technology 6.54%
3. Amazon.com Inc Retail 5.91%
4. Meta Platforms Inc Cl A Information Technology 4.93%
5. Alphabet Inc Cl C Information Technology 4.77%
6. Thermo Fisher Scientific Inc Healthcare Equipment 4.41%
7. Eli Lilly and Co Drugs 3.72%
8. Apple Inc Computer Electronics 3.59%
9. Abbott Laboratories Healthcare Equipment 3.11%
10. Danaher Corp Healthcare Equipment 3.00%
11. Merck & Co Inc Drugs 2.99%
12. Broadcom Inc Computer Electronics 2.78%
13. Gilead Sciences Inc Drugs 2.69%
14. DexCom Inc Healthcare Equipment 2.44%
15. Johnson & Johnson Drugs 2.14%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.